fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

How the Vac4covid study will collect data

Written by | 7 Apr 2021

Interview and article by Christine Clark. Gavin Dobson, Clinical Trials Pharmacist at MEMO Research explains the practical details of the Vac4covid study. The Vac4covid study will recruit at… read more.

Studying people’s experience of covid-19 vaccination – Vac4covid

Written by | 6 Apr 2021

Interview and article by Christine Clark. The Vac4covid study has been designed to provide important data about the safety and effectiveness of covid-19 vaccines. IMI interviewed Mr Gavin… read more.

Pfizer-BioNTech announce positive topline results of pivotal COVID-19 vaccine study in adolescents

Written by | 4 Apr 2021

Pfizer Inc. and BioNTech SE announced that, in a Phase III trial in adolescents 12 to 15 years of age with or without prior evidence of SARS-CoV-2 infection,… read more.

CHMP issues advice on the use of Celltrion’s regdanvimab (CT-P59) for COVID-19 patients in the European Union

Written by | 1 Apr 2021

Celltrion Group announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive scientific opinion for the company’s anti-COVID-19 monoclonal antibody… read more.

ASHP publishes reports exploring pharmacy’s role in future of healthcare delivery

Written by | 1 Apr 2021

ASHP (American Society of Health-System Pharmacists) today announced the publication of two landmark reports that articulate a futuristic vision for pharmacy practice, including expanded roles for the pharmacy enterprise… read more.

Personal values & worldviews shape perception of disease risk more than its severity

Written by | 29 Mar 2021

Study taken throughout the pandemic shows those who feel government should be less controlling believe COVID-19 poses less risk, which in turn was associated with the adoption of… read more.

AZD 1222 US Phase III primary analysis confirms safety and efficacy for prevention of COVID-19 – AstraZeneca

Written by | 27 Mar 2021

Positive high-level results from the primary analysis of the Phase III trial of AZD 1222 in the US have confirmed vaccine efficacy consistent with the pre-specified interim analysis… read more.

Real world evidence from Peru and Colombia confirms ivermectin safe and effective

Written by | 27 Mar 2021

Interview and article by Christine Clark. The real world evidence about ivermectin combined with the findings from meta-analyses of clinical trials provide compelling evidence for the safety and… read more.

Colombian ivermectin study – how protocol violations influenced results

Written by | 26 Mar 2021

Interview and article by Christine Clark. The results of the recent controlled trial of ivermectin for covid-19 in Colombia suggest that both ivermectin and control groups received ivermectin,… read more.

Protocol violations in Colombian ivermectin study compromise results

Written by | 25 Mar 2021

Interview and article by Christine Clark Dr David Scheim explains how multiple protocol violations and widespread use of over-the-counter ivermectin could have compromised the results of a recent… read more.

Real world evidence from Israeli Ministry of Health analysis confirms high effectiveness of the Pfizer-BioNTech COVID 19 vaccine

Written by | 24 Mar 2021

The Israel Ministry of Health (MoH), Pfizer Inc. and BioNTech SE announced real-world evidence demonstrating dramatically lower incidence rates of COVID-19 disease in individuals fully vaccinated with the… read more.

Ivermectin in Peru – results that save lives

Written by | 24 Mar 2021

Interview and article by Christine Clark Dr David Scheim explains how the original analysis factored out confounders and showed a 74% reduction in deaths at 30 days as… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.